Udemy, Inc.
UDMYInvestment snapshot
Positive
3
BUY / PASS
Neutral / negative
2 / 11
NEUTRAL / FAIL
Median fair value
$2.90
-32.4% vs price
Models with upside
2 / 17
Positive margin of safety
Strongest signal
7 of 10 pass — Marks, Sleep and Oshaughnessy object
Key risk
No clean pass — all 8 investors flag at least one efficiency criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | Not ranked | BUY | FAIL | FAIL | FAIL | FAIL | FAIL | PASS | FAIL | PASS | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||
| Margin of Safety | -333.3% | -125.8% | N/A | N/A | N/A | N/A | +58.3% | -47.9% | N/A | N/A | +64.1% | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-03-31 · Balance sheet at 2026-03-31 · Annual history · FY 2025 Latest source filing: 2026-05-11 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-19 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-03-31 vs 2025-03-31 · TTM ended 2026-03-31 Latest source filing: 2026-05-11 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-19 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-19 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-03-31 · Balance sheet at 2026-03-31 · Market data at 2026-04-10 Latest source filing: 2026-05-11 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-19 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-19 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-03-31 Latest source filing: 2026-05-11 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-19 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-03-31 · Market data at 2026-04-10 Latest source filing: 2026-05-11 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-04-10 Latest source filing: 2026-02-19 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-19 Score computed: 2026-11-14 | TTM ended 2026-03-31 · Balance sheet at 2026-03-31 · Price history 2025-01-01–2026-04-10 · Annual history · FY 2025 Latest source filing: 2026-05-11 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-03-31 Latest source filing: 2026-05-11 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-03-31 Latest source filing: 2026-05-11 Score computed: 2026-11-14 | TTM ended 2026-03-31 · Annual history · FY 2025 · Price history 2025-01-01–2026-04-10 Latest source filing: 2026-05-11 Score computed: 2026-11-14 |
Where It Passes
- Cash Flow70% pass✓ 9✗ 3▾
7 of 10 pass — Marks, Sleep and Oshaughnessy object
Free Cash Flow Proxy$23.4M✓BuffettPositive and growingFCF Positive and Growing$86.9M✓LynchPositive and growingOperating Cash Flow$87.7M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=14.19%, ROA=0.62%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)7.1x✓Dreman< 8xP/E or FCF YieldP/E=143.0x, FCF Yield=13.2%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive3/7 years FCF positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap13.9%✓Ackman>= 4%Price / FCF per Share7.6x✓Ackman<= 25Positive Operating Cash Flow frequency3/7 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$86.9M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+13.97%; #457/4519 (top 10.1%)✗OshaughnessyTop 10% of eligible cross-section
Where It Falls Short
- Efficiency0% pass✓ 1✗ 10▾
No clean pass — all 8 investors flag at least one efficiency criterion
Current Ratio1.28✗Graham>= 2.0ROIC (3-5 yr avg)✗Buffett> 10%ROIC - WACC✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)N/A (invested capital <= 0)✗Greenblatt> 25%Current Ratio Change YoY1.27 -> 1.31✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.30x -> 1.28x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities1.28✗Dreman> 1.5Return on Invested Capital✗Munger> 15%ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)✗SleepROIC > 12% in a majority of years - Profitability6% pass✓ 8✗ 27▾
15 of 16 flag UDMY's profitability — Graham, Buffett, Lynch +12 more
Positive EPS (10 years)1/8 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthNet Income Positive (10+ years)1/8 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-27.5%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)-0.5% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$23.4M✓BuffettPositive and growingEarnings Variance (10-yr CoV)N/A (negative mean EPS)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)P/E 143.0x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE-3.3%✗Lynch> 15%EBIT / Enterprise Value-1.1%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-1.1%, ROC=N/A (invested capital <= 0)✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets0.62%✓PiotroskiROA > 0ROA Change YoY-14.08% -> 0.62% (delta: +14.70%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=14.19%, ROA=0.62%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY62.5% -> 65.6%✓PiotroskiImproved YoYPre-Tax Income / Revenue-0.2%✗Dreman>= 8%Net Income / Shareholders' Equity-3.3%✗Dreman> 12%Margin of SafetyP/E=143.0x, P/B=3.0x✗PabraiP/B < 1.5 or P/E < 15Return on Equity-23.8% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency1/7 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue-1.6%✗Ackman>= 15%Net Income / Shareholders Equity-3.3%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-16.7% (2023) -> -0.5% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 57.5% -> 65.6%, operating margin -16.7% -> -0.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization-1.13%; #3432/6340 (top 54.1%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+81.66%; #235/3702 (top 6.3%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity-3.32%; #3123/5226 (top 59.8%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0706; #3036/5884 (top 51.6%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years1/7 years positive✗Schloss>= 70% positive over 5-10 observed years (app rule) - Debt & Leverage8% pass✓ 1✗ 14▾
11 of 12 flag UDMY's debt & leverage — Graham, Buffett, Lynch +8 more
LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest Coverage✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities1.28✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00xDebt Levels✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=-13.9x, D/EBITDA=N/A✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity✗Ackman<= 1.0Negative debt-to-equity (higher means less debt)✗AsnessTop 30% of eligible cross-section - Growth13% pass✓ 5✗ 8▾
7 of 8 flag UDMY's growth — Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)P/E 143.0x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthN/A (no inventory)✓LynchInventory growth < Revenue growthEPS Growth Direction$-2.57 (2019) -> $0.03 (2025)✓DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency1/7 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth7.9%✓Ackman>= 5%Positive EPS Growth Frequency5/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 57.5% -> 65.6%, operating margin -16.7% -> -0.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR12.9%✓SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Valuation15% pass✓ 3✗ 25▾
11 of 13 flag UDMY's valuation — Graham, Lynch, Greenblatt +8 more
Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio3.0x✗Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)P/E 143.0x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value-1.1%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-1.1%, ROC=N/A (invested capital <= 0)✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS143.0x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)7.1x✓Dreman< 8xPrice / Book Value per Share3.0x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=143.0x, OE Yield=3.7%✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=143.0x, FCF Yield=13.2%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=143.0x, P/B=3.0x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePrice / FCF per Share7.6x✓Ackman<= 25Price vs. Trailing Low✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization-1.13%; #3432/6340 (top 54.1%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.3410; #3506/6449 (top 54.4%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS143.0x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share3.19x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+1.2550; #1535/5247 (top 29.3%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+13.97%; #457/4519 (top 10.1%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date✗OshaughnessyTop 10% of eligible cross-section - Verdicts21% pass✓ 3✗ 11▾
Split decision: 11 FAIL · 2 PASS · 2 NEUTRAL · 1 BUY
Overall verdict✗GrahamFAIL (1/9)✗BuffettFAIL (2/9)✗LynchFAIL (2/7)•GreenblattNot ranked✓PiotroskiBUY (F-Score 8)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (1/3)✗AkreFAIL (1/6)✗MarksFAIL (0/5)✓AckmanPASS (5/9)✗TempletonFAIL (2/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (0/7)•OshaughnessyNEUTRAL (Not ranked) - Valuation models40% pass✓ 2✗ 3▾
Models split on UDMY at $4.29 — fair values range $0.99–$11.94
Graham fair value$0.99✗Graham-333.3% margin vs $4.29Buffett fair value$1.90✗Buffett-125.8% margin vs $4.29Munger fair value$10.28✓Munger+58.3% margin vs $4.29Pabrai fair value$2.90✗Pabrai-47.9% margin vs $4.29Ackman fair value$11.94✓Ackman+64.1% margin vs $4.29
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 1.6% of shares last year, 8.0% over two.
- Buybacks
- $51.0M
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-03-31 2025-04-01 – 2026-03-31 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex, buybacks, revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense. | Q1 FY 2026 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|
| Market Cap | $622.3Mcurrent | -- | $699.5Mest. | $1.1Best. | $2.1Best. | $1.8Best. | $890.6Mest. |
| Revenue | $781.0M↓1% | $191.4M↓4% | $789.8M | $786.6M↑8% | $728.9M↑16% | $629.1M↑22% | $515.7M |
| Operating Income | -$12.2M↑83% | -$12.5M↓179% | -$4.2M↑95% | -$89.3M↑27% | -$121.9M↑19% | -$151.2M↓94% | -$77.9M |
| Net Income | -$7.0M↑90% | -$12.6M↓612% | $3.8M↑104% | -$85.3M↑21% | -$107.3M↑30% | -$153.9M↓92% | -$80.0M |
| EPS (Diluted) | -- | $-0.09↓800% | $0.03↑105% | $-0.56↑21% | $-0.71↑35% | $-1.09↑25% | $-1.46 |
| Gross Margin | 66.4%↑5% | 67.5%↑5% | 65.6%↑5% | 62.5%↑9% | 57.5%↑2% | 56.2%↑4% | 54.2% |
| Operating Margin | -1.6%↑83% | -6.5%↓192% | -0.5%↑95% | -11.4%↑32% | -16.7%↑30% | -24.0%↓59% | -15.1% |
| ROE | -3.3%↑90% | — | 1.8%↑104% | -43.2%↓44% | -30.1%↑34% | -45.3%↓121% | -20.5% |
| Total Debt | -- | -- | -- | -- | -- | -- | -- |
| Shareholders' Equity | $212.2M↑1% | $212.2M↑1% | $210.5M↑7% | $197.4M↓45% | $356.9M↑5% | $339.3M↓13% | $389.7M |
| Current Ratio | 1.28 | 1.28 | 1.31↑3% | 1.27↓23% | 1.66↑5% | 1.59↓15% | 1.88 |
| Debt / Equity | — | — | — | — | — | — | — |
| Operating Cash Flow | $90.9M↑105% | $15.4M↑26% | $87.7M↑65% | $53.0M↑2746% | -$2.0M↑97% | -$61.0M↓758% | -$7.1M |
| Free Cash Flow | $86.9M↑118% | $14.9M↑52% | $81.9M↑61% | $50.7M↑2024% | -$2.6M↑96% | -$62.5M↓403% | -$12.4M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Personal Services
UDMY vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| New Oriental Education & Technology Group Inc.EDU | $8.3B | $53.28 | $4.9B | $371.7M | 10.2% | 0.00 | 8.7% | 1.58 | 1/9 | 2/9 | 3/7 | 1/3 | F-Score 7 | 6/11 |
| H&R BLOCK INCHRB | $6.1B | $50.01 | $3.8B | $605.8M | 681.4% | 20.73 | 22.0% | 0.90 | 3/9 | 4/9 | 3/7 | 1/3 | F-Score 4 | 4/11 |
| Graham Holdings CoGHC | $5.2B | $1244.05 | $4.9B | $292.3M | 6.1% | 0.18 | 4.8% | 1.75 | 6/9 | 0/9 | 3/7 | 0/3 | F-Score 6 | 5/11 |
| LAUREATE EDUCATION, INC.LAUR | $4.8B | $35.03 | $1.7B | $281.6M | 23.7% | 0.11 | 25.3% | 0.67 | 1/9 | 5/9 | 6/7 | 3/3 | F-Score 6 | 4/11 |
| UNIFIRST CORPUNF | $4.3B | $235.39 | $2.4B | $148.3M | 6.8% | — | 7.6% | 3.18 | 3/9 | 5/9 | 2/7 | 0/3 | F-Score 6 | 3/11 |
| Covista Inc.CVSA | $3.9B | $118.17 | $2.0B | $251.6M | 17.4% | 0.46 | 19.6% | 1.09 | 1/9 | 4/9 | 5/7 | 0/3 | F-Score 6 | 4/11 |
| BRIGHT HORIZONS FAMILY SOLUTIONS INC.BFAM | $2.5B | $52.68 | $2.9B | $193.1M | 14.4% | 0.56 | 10.7% | 0.52 | 1/9 | 1/9 | 4/7 | 0/3 | F-Score 8 | 3/11 |
| UNIVERSAL TECHNICAL INSTITUTE INCUTI | $1.2B | $21.99 | $835.6M | $63.0M | 19.2% | 0.27 | 10.0% | 1.07 | 1/9 | 4/9 | 1/7 | 0/3 | F-Score 6 | 2/11 |